» Articles » PMID: 27698592

Treatment Planning Study of Volumetric Modulated Arc Therapy and Three Dimensional Field-in-field Techniques for Left Chest-wall Cancers with Regional Lymph Nodes

Overview
Specialty Oncology
Date 2016 Oct 5
PMID 27698592
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: This study aims to investigate whether there are dosimetric advantages to using VMAT (Volumetric Modulated Arc Therapy) for left-sided chest-wall patients over the three-dimensional conformal field-in-field (FinF) technique.

Background: There is a lack of dosimetric studies dedicated for chest-wall patients. Potential dosimetric advantage could be obtained using VMAT due to complex geometry of PTVs (Planning Target Volumes) and OARs (Organs at Risk) in chest-wall and lymph nodes.

Materials And Methods: VMAT and FinF plans were generated and evaluated based on DVHs (Dose Volume Histograms) for both PTVs and OARs for 22 left-sided chest-wall patients with involved regional nodes. PTV HIs (Homogeneity Indices) and CIs (Conformity Indices), and EUDs (Equivalent Uniform Doses) for PTVs and OARs were also evaluated for comparisons between VMAT and FinF.

Results: FinF planning met PTV criteria adequately in all cases except two. In these two cases, VMAT was able to meet PTV criteria adequately. VMAT demonstrated significant reduction in left lung V in chest-wall patients compared to FinF plans. The volumes of the right lung and right breast receiving 5 Gy were much higher in VMAT than those in FinF for all patients.

Conclusions: Compared to the FinF technique, there is a generally limited benefit using VMAT for left-sided chest-wall patients due to large low-dose-bath to OARs with insignificant improvement in PTV coverage. In case where FinF planning cannot meet dose constrains, VMAT provides a viable option. The use of VMAT planning over the FinF technique in chest-wall cancers should be carefully analyzed on an individual basis.

Citing Articles

Correlations between patient-specific parameters and dosimetric indices for personalized breast cancer radiotherapy.

Costin I, Marcu L Sci Rep. 2024; 14(1):26141.

PMID: 39478060 PMC: 11526019. DOI: 10.1038/s41598-024-75858-4.


Adjuvant Radiation Treatment of Breast Cancer After Mastectomy: Advanced Algorithms and Partial Bolus Improve the Dose Calculation Accuracy in the Case of Thin-Chest-Wall Irradiation.

Lundstedt D, Lindberg A, Gustafsson M, Chakarova R, Karlsson P Adv Radiat Oncol. 2023; 8(5):101223.

PMID: 37124029 PMC: 10130603. DOI: 10.1016/j.adro.2023.101223.


Assessment of Field-in-Field, 3-Field, and 4-Field Treatment Planning Methods for Radiotherapy of Gastro-Esophageal Junction Cancer.

Mehri-Kakavand G, Pursamimi M, Parwaie W, Ghorbani M, Khosravi M, Hosseini S J Biomed Phys Eng. 2022; 12(5):439-454.

PMID: 36313414 PMC: 9589079. DOI: 10.31661/jbpe.v0i0.2206-1500.


Dosimetric evaluation of VMAT and helical tomotherapy techniques comparing conventional volumes with clinical target volumes based on new ESTRO ACROP post-mastectomy with immediate implant reconstruction contouring guidelines.

Ozan Goksel E, Tezcanli E, Arifoglu A, Kucucuk H, Senkesen O, Abacioglu U Radiat Oncol. 2022; 17(1):168.

PMID: 36271401 PMC: 9587659. DOI: 10.1186/s13014-022-02134-y.


Dosimetric comparison of TomoDirect, helical tomotherapy, and volumetric modulated arc therapy for postmastectomy treatment.

Nobnop W, Phakoetsuk P, Chitapanarux I, Tippanya D, Khamchompoo D J Appl Clin Med Phys. 2020; 21(9):155-162.

PMID: 32715634 PMC: 7497934. DOI: 10.1002/acm2.12989.


References
1.
Beckham W, Popescu C, Patenaude V, Wai E, Olivotto I . Is multibeam IMRT better than standard treatment for patients with left-sided breast cancer?. Int J Radiat Oncol Biol Phys. 2007; 69(3):918-24. DOI: 10.1016/j.ijrobp.2007.06.060. View

2.
Chen Y, Thompson W, Semenciw R, Mao Y . Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev. 1999; 8(10):855-61. View

3.
Badakhshi H, Kaul D, Nadobny J, Wille B, Sehouli J, Budach V . Image-guided volumetric modulated arc therapy for breast cancer: a feasibility study and plan comparison with three-dimensional conformal and intensity-modulated radiotherapy. Br J Radiol. 2013; 86(1032):20130515. PMC: 3856548. DOI: 10.1259/bjr.20130515. View

4.
Niemierko A . Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys. 1997; 24(1):103-10. DOI: 10.1118/1.598063. View

5.
Wang S, Liao Z, Wei X, Liu H, Tucker S, Hu C . Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys. 2006; 66(5):1399-407. DOI: 10.1016/j.ijrobp.2006.07.1337. View